N
Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:jonas brothers500+steven kwan500+kings vs warriors200+steffi graf200+boxing200+ben simmons500+lisa500+bill maher500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "FDA Clears Clinical Trial" (30 stories)

Top Headline Story

FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke
Lead StoryPatient Care Onlinegeneral
3d ago

FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOYm5FS0RrREtnc1B4ZURwb2VnTlpoR3RuUV9NUnBKUFhsSW9aNHM2Wl9FVklYMEJMRmNOZG5heUdLRzM1Snc2RWVuQkVCYWZjSTZydDFDYV8wZ2xTenZfeXNvOTcxclZzSHp3QjNpU3M5eFpDRUVuZm5BZDB5RzRKbmJuWS1FRVZ5NDV0TVM1aU9uazdvQ2Z1Y1NtWE92ZDZvVmdEWnFncjhPdEhLZUtEelJTZ1huemVmcWQ4?oc=5" target="_blank">FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke</a>  <font color="#6f6f6f">Patient Care Online</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+20m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+20m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories
200+20m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

Filter stories
200+20m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Filter stories

Search Results for "FDA Clears Clinical Trial"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
FDA approves Rhapsido (remibrutinib) for symptomatic dermographism
The Clinical Trial Vanguardgeneral

FDA approves Rhapsido (remibrutinib) for symptomatic dermographism

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNVDRpRWhPTER4VldfSVJod3U5elVLWFNuN1JlYmtNRmJUQnplelN3WTdCV1pYUm5WUTI4YTNkclJwMk85MnZUR0Vsc0V0ektKbVVtcHN6SG1ZSUYxWkl3VGdkMjhsVUgwY2FaeWpCSktLRjYwRmJhV2RWZENJeDVmamRTMW1OMklZNU4yYzlqYS1yOVNrSzRVU294YWdLQk5zOGtxUE1USDJmOXl6?oc=5" target="_blank">FDA approves Rhapsido (remibrutinib) for symptomatic dermographism</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
AML Drug Moves Into Clinical Trials Following FDA Clearance
Technology Networksgeneral

AML Drug Moves Into Clinical Trials Following FDA Clearance

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOcElmdy1KTzJZWWxOXy1IZG5QUFlQa3NHdkFxTS1zR3JRRE9KUFMyLXhFOVBMcFc4WUhJckktYmpnbEJ4NkFMMFJaa2pkaXZxUEVJTVRZbHBjMGFyUzhIX0ViYVZhQ1E4blZIT0J4ZGR1TWxSbTBkNTNWMVNVLWlkRGU0M0IxOVpzUDVEZDFXTy1pa0MzVG02VktBeVRqMkJMaFF2eE8xaFYwUmJBc1J6QTNDc29wWHJPSWJ1MW00Q19Ba0U?oc=5" target="_blank">AML Drug Moves Into Clinical Trials Following FDA Clearance</a>  <font color="#6f6f6f">Technology Networks</font>

Read Full StoryMore like this
FDA OKs trial testing treatment for muscle regeneration in FSHD adults
Muscular Dystrophy Newsgeneral

FDA OKs trial testing treatment for muscle regeneration in FSHD adults

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQY3c2ZE83VlFKWm4tUkcwYk95OUlqdmFtM3NGVmdOeW82RDFqZU1admI0QWRyT1VLNFl3bGtIR3FIaHNVb0dpOGxRb0JUQlhLUktCVFZWN0w0QmhETGlfQl9TZjNYMi1uNGRKclRtb0hBRkNKQUFTRF9VUEo2WWZIcGtjYXFrZjN3US1LRFhpVGdYekptWkFQektoMkIxOGhrQ21wajRIVQ?oc=5" target="_blank">FDA OKs trial testing treatment for muscle regeneration in FSHD adults</a>  <font color="#6f6f6f">Muscular Dystrophy News</font>

Read Full StoryMore like this
FDA clears HanchorBio's trispecific immunotherapy HCB303 for clinical trial
Dealroomworld

FDA clears HanchorBio's trispecific immunotherapy HCB303 for clinical trial

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNamVKTWJyTk9ZZmZjQUxjSHhqZ2FjM09GSDJjSG42V0E4YlBEaXdvWXlub29Tak5xbTFYSENfb3pIQURTTi1EU24zM3Z5S1JPaTlGNDVUMmY4MmhzMzBJWHUyWnVZcFBQeGFCOUZsYmY2ZzRvdVp5aW81U3N2T3h4VUEtWlREZnRDazkzQlJlaW9iMnJDXzFTNWxPME5BQUlxaElNdVBENVdnQmdqanc?oc=5" target="_blank">FDA clears HanchorBio's trispecific immunotherapy HCB303 for clinical trial</a>  <font color="#6f6f6f">Dealroom</font>

Read Full StoryMore like this
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer
University of Colorado Anschutzgeneral

FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer

<a href="https://news.google.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?oc=5" target="_blank">FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer</a>  <font color="#6f6f6f">University of Colorado Anschutz</font>

Read Full StoryMore like this
FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
Psychiatric Timesgeneral

FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNZTJfUHFFYlgtYkpVZ1BaaVNkaHZKdGRrakJoTVIwUFBDcXBPdlk4a2ZodXJVdVlybGFvU2dCNlE1MFVyUWU3N3BRMExDLXhFN2dXNHNNRTBvenFBUHRHOV8zOEh2d3M1QzdKV0FXTXZCUkZnRFFOWl9ILWFxVGxOZEVuM3NuN1pqeE4yVjVtb0FYN3JPQTdINjZDNWw5OWxLd21fMFQ2Ukc2cEhtSU96c0RRLWhQRW5VckVxREV4QmlveHlPVUswMkVNT2FKU2l3ZXRxY2E2TnA?oc=5" target="_blank">FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia</a>  <font color="#6f6f6f">Psychiatric Times</font>

Read Full StoryMore like this
Satellos stock jumps after FDA clears FSHD trial for forazapadin
Yahoo Financemarkets

Satellos stock jumps after FDA clears FSHD trial for forazapadin

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQSzd6YWsxOTZHV3FMUHVCb1JQU011Y0J0ZGtDWGtSQ3BSNlNwY1Nybk11UG5wNURVR0lmZ2d6QjFNVmRiYWNPR3N2d2JCU1d1cVFnMS1mekgyN2NEOE5kUmF0R0YyWlZFYTFNaUk4bDlQN2hMY0xsTExMdHZfTFMwRFZwYzhVbU1xYnVVcDVIRGN2czQzNGhF?oc=5" target="_blank">Satellos stock jumps after FDA clears FSHD trial for forazapadin</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial
Clinical Trials Arenageneral

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOQ3JJMlJRNC1YdmNqQ200ZTNhMDJMTE9ncEZkbERGcFcxdHBILWt2d0l6S0N4NVJWbjRQYkZiV29OVDdoYzB6MlpJYmRGUXhLQkNsOERZN2NObk84WHdYY09GdXBGSTV1bEc3Y0Jwang3dnl3aU8wNGZIU1ZyV3lRZy1paXpSVnBTTEs0Ng?oc=5" target="_blank">FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder
National Center for Advancing Translational Sciences (.gov)general

FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQSldqMjNfT2xyOHpIRUlZRzRwRk1KSWV2cTh1RU5vNF9lVVhzNVI1a280bTROcDNySzBQbXA2a3BscTFJUndFaHlWN3UwSS13cXBnc1JjWFRKbkpQczBGWXFKR3JWUnNQSkhuRWxaTXhJX2RGRk9Dc2xPMEd1alVOQS1CcWhVSEpodkRDN1BlVHlnbS16dXozVXlDQzd5U2sweU5PMUszdDE1TENBSElpcGRR?oc=5" target="_blank">FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder</a>  <font color="#6f6f6f">National Center for Advancing Translational Sciences (.gov)</font>

Read Full StoryMore like this
FDA clears first human trial of epigenetic reprogramming therapy
Longevity.Technologygeneral

FDA clears first human trial of epigenetic reprogramming therapy

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOTXR5emVCYUJsM3JCb3M5WVlMUHlTbTZvUEZYWGt0WWVpdldWSzYtLTRrbExuc1JQWU9UUjlrb0g1aUxJbWNfLXZhVDJOUTFaVVZBZ0JnQnJTY3Z5VHp0di0xSHVjTkNDV2JCdkpLUmtuSDYxMjB1dVNlWXRHRFdrWjR4ai1Mci1NX2E1X2tSemdhdUhVMG9sa3pDV0trRTEx?oc=5" target="_blank">FDA clears first human trial of epigenetic reprogramming therapy</a>  <font color="#6f6f6f">Longevity.Technology</font>

Read Full StoryMore like this
FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis
NeurologyLivegeneral

FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNZk0wWEpGODZueVdKUHRaUk9YYXRuNDNydTVrcU9rSVhyd1FIZGN3LW5pWVIzMk5ZVFVaQ1hsOUFvaXNvWndJS0NVYkF2dmI1VFM3eVRmX1QwckNtQWk3R1lJYjBhMFk1d2tCal9xUnMzU1BtcHRaTE1CNENQbi1rb0JrbzNOTDQycXpaUlo3Nlp6U19VcHUxLVF2bEhsQ2c0TDRWMA?oc=5" target="_blank">FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
FDA action clears major hurdle for DOT oral fluid drug testing
TheTrucker.comgeneral

FDA action clears major hurdle for DOT oral fluid drug testing

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxONkpIeTZyTC1SWE42N0szeS1UUU5xVklNZDdGQTh3XzJMMXM3M3hsQXJsWTFYOXBwMUl3S0ZtWjctcGxqZ2RURlpMckJoQnBzbHZPTjMyN2w0TWZYZFVhTlAwTTFaY0xJazR1Nm53d1FwOXVoemdvaXlGdE5MZmppVHZORXZWcnh0aXR5M3FSUjBFUnZZejhwVGJxTDlaYnR4YlFhQk5VazFfUHRNRTV6djdB?oc=5" target="_blank">FDA action clears major hurdle for DOT oral fluid drug testing</a>  <font color="#6f6f6f">TheTrucker.com</font>

Read Full StoryMore like this
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
Life Biosciencesscience

Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNdUlCamJkZURkcVgtZFlqZi0zWHNVSUFwcndSWWx3SkpVaEJEUXh2NU5PZm9falZlQS03SktoNUZRWXNDb1RYRFNrN3YyUHRPYXlfdEJ0R3Nud0JNX0Y0bk4tcHNrdlRqakhkVS14WjJ0enFSVGg0TGk2Sk9nN2kyeGpEOVJDWGNnYU8yV1NaSGdXSlBWcHdiRlBSVWxwel9PYVQyczk1bllPQmRab1h4WVpLWXBQZmthN19PV0h6bEx2N1U?oc=5" target="_blank">Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies</a>  <font color="#6f6f6f">Life Biosciences</font>

Read Full StoryMore like this
About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application.
Stock Titangeneral

About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application.

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOY2hQak1Wd3MtcDU0aDNtdXM5REljUjVYdTdneTZHeHE3b1A5MVFhZkdjSElnN2RYOFdzLWpkNWx4ZU5zVTR5UmU5M0dKb3Zwc2lreTRZRTFCcHVYZEo3QVkydWgzWnBYVjU5XzhsUEdTS3JyZThzaER5RndvajVLcDdYMERMNEd0ZmJ2c0pEcllOUEdyREpGOXBuSVNxYTdLS0lLeWpjbGJpZUdJS2pnVVJqbjhvYks2WW15bUhqc2Q?oc=5" target="_blank">About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application.</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM
CancerNetworkgeneral

FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQaWJLQVRpcWdIU180WEVsc3RsZXBJTTM4eGk3Z3RTTHhRMlhNdzZLaV9CRmRwbDdid0ZWVEtfQmN0U0tJX0dpcmxJZzNFa1RuTFpuT1RySUpKdjdmMlY2c0FUb0ZGX2tQMEM4eXd5NUNqLWk5eWxQTXBfdEJqN0hDdDdUckNEaWthYWZ4Nml2THljUUY5ajRMdnJ2Z1c?oc=5" target="_blank">FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
Patient Care Onlinegeneral

FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQeXpzd0tUdFRKdUFiT0Rnd2NnVWNOdlhIcWg1WWdWQ0pvdjBKQ2JyWHE3QlNSdGVESnZQTUFhTHZPeUQzVG1LUFp1eXM4ajdqaFhNeVFmQ2ZhWWRhREVJUU82dXVuc2VPbldQVHNYa09mam15V2h6aXM3Z3gwX05sVlB5MVE3T3phMXdKQ1RiV1d4clAwYUJmdDg1eERWR2d5UkNWbDFZbzlfMU1iLUY0NU1VSUV4QQ?oc=5" target="_blank">FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia</a>  <font color="#6f6f6f">Patient Care Online</font>

Read Full StoryMore like this
FDA Clears PrecivityAD2 Blood Test for Alzheimer’s in Adults as Young as 40
The Clinical Trial Vanguardworld

FDA Clears PrecivityAD2 Blood Test for Alzheimer’s in Adults as Young as 40

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxORU9rQkdCblpESTg4aEwzMjZ3TVJJalpCSHhsY0l1YWVxakllZjVUc3NnSDZ3UzBWTjJ0Mkt4T24yVkRISDE1SHV6eXFRLWNoNVdMNnhWY1FwQW1NaDZBS28tT0dFYzZZdnZ2M1ctQm5rdXYzbUQtYTRhTmhNOVZPc2tBNEgtd3AwNzlGUmpPZ01lZGp1ekljUURwMXRra0ptYXJCbDBtOVJ4WkxhOUNsVjVNcW9PeGxjOXc?oc=5" target="_blank">FDA Clears PrecivityAD2 Blood Test for Alzheimer’s in Adults as Young as 40</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
FDA Clears Clinical Trial of NRX-101 in Combination with Robotic-Enabled TMS in Patients With Depression and Suicidality
Psychiatric Timesgeneral

FDA Clears Clinical Trial of NRX-101 in Combination with Robotic-Enabled TMS in Patients With Depression and Suicidality

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOcEJKYV9BV1dydUNMTks5VDRrUDlHVVhVRm5iUWJvYmQ5bDhnQVkwNzl5VTR4eDV1Z0YwakVQTVdQLVh4OHBjU1RsNXhSSmE2amRUVzRsbjI3T0FsMkNmSmhiTWo1THdSeThBM2V2MENXMlNtelZ0TWw4VHVieXBaYXRQTW4td0tzb1E5RXNLeWVSQml5cjdFekVSd1hRc2RaSDMxd1JOdk0wV01jZ1lWVDRnNkc0VEpwRFdORGF6RGh3N01xOWctWWkzQmRuNG1IcGpBU0FaYjQxVWFSNUtISGp1YjRTY3Q2RndXUE5vdw?oc=5" target="_blank">FDA Clears Clinical Trial of NRX-101 in Combination with Robotic-Enabled TMS in Patients With Depression and Suicidality</a>  <font color="#6f6f6f">Psychiatric Times</font>

Read Full StoryMore like this
FDA Clears Phase 2 Trial for Myelin Protective Agent Lucid-MS in Progressive Multiple Sclerosis
NeurologyLivegeneral

FDA Clears Phase 2 Trial for Myelin Protective Agent Lucid-MS in Progressive Multiple Sclerosis

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOWUI3UTFPRVNINkg2Um11aU1sNXBpRi1jeUJSVkVqRENENGxTZTdFb2g4azE1eEpOR1c5SG8yUGcteHJRbE5ENVEzdW5HUFVXSnFFeUZtOGE5dGRfc1FwVTYyRlBUbWV6QVBqQnhuTlM0Z2VjaEoxdnhNS1lWNHZHdjZnbDh3dUN0VktYTmVGVVlEVnRFOUo4WW5fdkFTSDBtb3ZoN0NiS051RmFZZkJmM19ER2tpVGRucmQw?oc=5" target="_blank">FDA Clears Phase 2 Trial for Myelin Protective Agent Lucid-MS in Progressive Multiple Sclerosis</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
FDA Approves Lyrfigtu for FGFR2-Rearranged Cholangiocarcinoma
The Clinical Trial Vanguardgeneral

FDA Approves Lyrfigtu for FGFR2-Rearranged Cholangiocarcinoma

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWTExVXcteTJ0TTRSWnN1U1FWRklJM2dxUzNZa3Y0clpHY3ZLODVoNS1zUmU0X0FfUXpxYVRva2tLWElNb3k3ZjRMcDN3S2xmTFMySVpGek9LZmlyMjZwUTg4QWtSSmhDa0Z4cHVxQ3RvczVfVVE5eU50Q1lNazZiaU9rMldvQ0s4TVFKeGQwOGJGODkwMElfN1p6NVAwRElOSlJCcTNSN28?oc=5" target="_blank">FDA Approves Lyrfigtu for FGFR2-Rearranged Cholangiocarcinoma</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
MIT class project turns into an FDA-cleared treatment for tremors
MIT Newsgeneral

MIT class project turns into an FDA-cleared treatment for tremors

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQajJ0c0xEak45ZXRvd3hMbm0zYUtWVVFNeGZwSWJIdmtJR0VIWGpWTDlRbG94c3FNUXJsXzMwXzY1MU5YYzE1b3BUeEJGR3E2cnBoSzlReDhmQUlVMEJjMGwzTmJiNzBRX2ZnelFLVjFHcWYya2NMV2NIaGdkRW51d2hTdHdOb2kzbnJyRnk2cDBmRUhDZHpISQ?oc=5" target="_blank">MIT class project turns into an FDA-cleared treatment for tremors</a>  <font color="#6f6f6f">MIT News</font>

Read Full StoryMore like this
FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion
Targeted Oncologygeneral

FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxObjIzV3BiaWNLMUhBdXIyajBBTXB4ZnhwUFFoQnhac0paUFRGdUk5Q1U3dkYxdTBlZHNPZFN0aDJ4WnZQbEwtc1FoVzNnMWt4U21iZmt1SnViWF91Q0FHa1NyRjRGVnVHT2gyYUxSVl9Ta3h6N2x3N1REV1g1RDBxMFdNQlg0bTdsNzc4LXhZMENNT1pyeFQtYzJYT0lfSlZERDVBaEtR?oc=5" target="_blank">FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
FDA clears blood test to aid evaluation for Alzheimer’s disease
WashU Medicinetech

FDA clears blood test to aid evaluation for Alzheimer’s disease

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQMUxOOFRaYW9xTEpoUGpJdFpMRFNZNUllV1o0bXQ0a09POGFDRWxOZ1ROa04yQ2xVcDJreklLajdYUzJzTUd4MTFXX0hJVFNWdG1fdmhCLWhTVTVlclJHUC1ua1FNZEZYcWdrbDBlSzdiY3MzbWtqbkk5eVFJUTB5dzJTY2llV0VSYnROZ29XaEdNM2xnSncxalVRSQ?oc=5" target="_blank">FDA clears blood test to aid evaluation for Alzheimer’s disease</a>  <font color="#6f6f6f">WashU Medicine</font>

Read Full StoryMore like this
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
CancerNetworkgeneral

FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOblNiMXNzZzhVcUhnYmt5RHpGTG1YU0xmLTk0UEYwU1hiX21fQ3Y4clRpeHJfaXNDTWpaR0xqVVdjYWZaZkpwakY2U0xQNGNjY2U0WWhUc3NIaE5WeVdEeDNaU0doZXhZUnRrenQwRzgxaDIxeXpQR3FpYUFTSVU2eGJjNXltX0Z1YXFoMEFwbjkyV2VReGc1bUxTWEp5ZjlBOTFEdXNvZ3Vpc2JoYTJBZzVMZk1EQQ?oc=5" target="_blank">FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
FDA Approves Tavapadon for Parkinson’s Motor Symptoms
The Michael J. Fox Foundation for Parkinson's Researchgeneral

FDA Approves Tavapadon for Parkinson’s Motor Symptoms

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNM1dUMjl2U3lNU0NqZmsyQ3IwZVFCSEFpMUdLY2VVTFlNSmZvMUQ0SVRpM2o3MHFpb3VSdUZmMXkza1pzdWFBRjhnd0l5aDBmMHdQVE9CSWZJYjRMVWltZ2wtUU0yakZEWGpSNmotamF5VkdWbEI4eVh0YjltVGNSeUo3Y3QyczZ1?oc=5" target="_blank">FDA Approves Tavapadon for Parkinson’s Motor Symptoms</a>  <font color="#6f6f6f">The Michael J. Fox Foundation for Parkinson's Research</font>

Read Full StoryMore like this
FDA Clears Investigational New Drug Application for Phase Ib/IIa Trial of CK0802 in Steroid-Refractory Graft-Versus-Host Disease
Applied Clinical Trials Onlinegeneral

FDA Clears Investigational New Drug Application for Phase Ib/IIa Trial of CK0802 in Steroid-Refractory Graft-Versus-Host Disease

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxNSm1QOXNZeXE3bUtWU29iOHdXWXlWblk5ZTVvdXFLMHZyUnRnd0RUSnRpX0FLWUZpZjQ1Ulk3b0NVZ0pfYlJudUVqZ3RwMEVaN0ttdjFkWTFYbFZrTUprbW5sSDZqVU5aVU9iRDJ2eEhRNmJNa3BHVjhVWlZxRFhXZWRFMkR6OHQyb2lEXzdjT2pnOTdEY195ZUszLTVSNFFsM1hYNjktaHNYYzJSMV91b1M4ek9WVGg5SHQ1blE3LWdUUEFHaGE3bVp4czBwaFRoNmVlMjhwdXI5Z0ZUUzdGNURzMzFzcjJubm1hR2FCeXlFcFg2aFRtUmtQOA?oc=5" target="_blank">FDA Clears Investigational New Drug Application for Phase Ib/IIa Trial of CK0802 in Steroid-Refractory Graft-Versus-Host Disease</a>  <font color="#6f6f6f">Applied Clinical Trials Online</font>

Read Full StoryMore like this
FDA Clears IND for Umoja’s UB-VV400 In Vivo CAR T Therapy
The Clinical Trial Vanguardgeneral

FDA Clears IND for Umoja’s UB-VV400 In Vivo CAR T Therapy

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQOEx6YmhjV2hrOXYtd0NxX2JVQXVRZjZmQnpLQllockxBTEg0U2lrMmRsQ0hzVWZDeF9kVmlKZjBsbDZ5eVY2UF9BY0MxdW4ya2ZfcWc3WkI5dE1md3U1VEJGMVp4RFRBWFZqZU15YTVXaHViUHZQRmVuZlBJOFVJdnlTc19lQVd1VGRVREVUSFZHbDZDeWJKVFg0V1pqVjBmbnc?oc=5" target="_blank">FDA Clears IND for Umoja’s UB-VV400 In Vivo CAR T Therapy</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
FDA Clears Atrium Therapeutics' IND Application for Cardiomyopathy Drug
Diagnostic and Interventional Cardiologygeneral

FDA Clears Atrium Therapeutics' IND Application for Cardiomyopathy Drug

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQVHJUUE5tNjBNNzVKZ3AyR082WDVFS2Q3dmlzeEw0c2N4ejRFejc4dHgyOVNqNGloRjFLR1lvUHFmWDN0bGs2RzF3elRJQWEtc0F0al80NUZ4SUJ1dEkzM3BLTmYwUlhzalFaY3puTm5YX2tsaXYzNzR5aUZtNldLOFlFM0QtazVTcGVpS3JCWlVGaEVIVmk4M09zeHZuMTZDdDNKR0tR?oc=5" target="_blank">FDA Clears Atrium Therapeutics' IND Application for Cardiomyopathy Drug</a>  <font color="#6f6f6f">Diagnostic and Interventional Cardiology</font>

Read Full StoryMore like this
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss
ArentFox Schiffscience

The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPbjE5Wm5vZnBxVnBmWDFXVUZiNTdDM2tuamZyUzFFWF9rWGJlMEd5OHlZdlhqMDc4Z2hEQmNYOHFFakFkNWhPbGpjd2doUUIyWDBaempaZndXOGhpMU04UmhvU180VHZjaVc4NVgyVERDUi02c1V0N1V1SlVLRjRwX056bEtSRElKVDJjMGM5MlY3V1Bkb3F1X19ZRHFNLWtvU25CUERtSktVbTIySjgzdEFGTTZZcFFSU2dxQg?oc=5" target="_blank">The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss</a>  <font color="#6f6f6f">ArentFox Schiff</font>

Read Full StoryMore like this
"FDA Clears Clinical Trial" — Live Google News Trends & Headlines